BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35216831)

  • 21. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.
    Partridge AH; Ruddy KJ; Gelber S; Schapira L; Abusief M; Meyer M; Ginsburg E
    Fertil Steril; 2010 Jul; 94(2):638-44. PubMed ID: 19409543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of ovarian reserve before and after chemotherapy.
    Berjeb KK; Debbabi L; Braham M; Zemni Z; Chtourou S; Hannachi H; Hamdoun M; Ayadi M; Kacem K; Zhioua F; Fadhlaoui A; Bahri O; Chakroun N
    J Gynecol Obstet Hum Reprod; 2021 May; 50(5):102035. PubMed ID: 33307239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.
    Oktay KH; Bedoschi G; Goldfarb SB; Taylan E; Titus S; Palomaki GE; Cigler T; Robson M; Dickler MN
    Fertil Steril; 2020 Jun; 113(6):1251-1260.e1. PubMed ID: 32331767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Detection of Ovarian Dysfunction by Anti-Mullerian Hormone in Adolescent and Young Adult-Aged Survivors of Childhood Cancer.
    George SA; Williamson Lewis R; Schirmer DA; Effinger KE; Spencer JB; Mertens AC; Meacham LR
    J Adolesc Young Adult Oncol; 2019 Feb; 8(1):18-25. PubMed ID: 30281375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of cancer therapies on ovarian reserve.
    Gracia CR; Sammel MD; Freeman E; Prewitt M; Carlson C; Ray A; Vance A; Ginsberg JP
    Fertil Steril; 2012 Jan; 97(1):134-40.e1. PubMed ID: 22137491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
    Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
    Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Müllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy - A translational research project of the SUCCESS A study.
    Trapp E; Steidl J; Rack B; Kupka MS; Andergassen U; Jückstock J; Kurt A; Vilsmaier T; de Gregorio A; de Gregorio N; Tzschaschel M; Lato C; Polasik A; Tesch H; Schneeweiss A; Beckmann MW; Fasching PA; Janni W; Müller V
    Breast; 2017 Oct; 35():130-135. PubMed ID: 28732324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial.
    Wenners A; Grambach J; Koss J; Maass N; Jonat W; Schmutzler A; Mundhenke C
    BMC Cancer; 2017 Sep; 17(1):632. PubMed ID: 28877720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy.
    Dillon KE; Sammel MD; Prewitt M; Ginsberg JP; Walker D; Mersereau JE; Gosiengfiao Y; Gracia CR
    Fertil Steril; 2013 Feb; 99(2):477-83. PubMed ID: 23084267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diminished ovarian reserve in adolescent cancer survivors treated with heavy metal chemotherapy.
    Pruett M; Williamson Lewis R; Klosky JL; Effinger KE; Meacham LR; Cherven B
    Pediatr Blood Cancer; 2023 Aug; 70(8):e30448. PubMed ID: 37243931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
    Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
    Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of breast cancer on anti-mullerian hormone levels in young women.
    Su HI; Flatt SW; Natarajan L; DeMichele A; Steiner AZ
    Breast Cancer Res Treat; 2013 Jan; 137(2):571-7. PubMed ID: 23224236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovarian reserve in premenopausal women with breast cancer.
    Zong X; Yu Y; Chen W; Zong W; Yang H; Chen X
    Breast; 2022 Aug; 64():143-150. PubMed ID: 35691250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
    Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
    Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uses of anti-Müllerian hormone (AMH) measurement before and after cancer treatment in women.
    Dunlop CE; Anderson RA
    Maturitas; 2015 Mar; 80(3):245-50. PubMed ID: 25596814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum anti-Müllerian hormone concentration and follicle density throughout reproductive life and in different diseases-implications in fertility preservation.
    Liebenthron J; Reinsberg J; van der Ven K; Saenger N; Kruessel JS; von Wolff M
    Hum Reprod; 2019 Dec; 34(12):2513-2522. PubMed ID: 31782794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's).
    Clowse ME; Copland SC; Hsieh TC; Chow SC; Hoffman GS; Merkel PA; Spiera RF; Davis JC; McCune WJ; Ytterberg SR; St Clair EW; Allen NB; Specks U; Stone JH;
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1777-81. PubMed ID: 22127969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Follow-Up of Chemotherapy-Induced Ovarian Failure in Young Breast Cancer Patients: The Role of Vascular Toxicity.
    Ben-Aharon I; Granot T; Meizner I; Hasky N; Tobar A; Rizel S; Yerushalmi R; Ben-Haroush A; Fisch B; Stemmer SM
    Oncologist; 2015 Sep; 20(9):985-91. PubMed ID: 26099742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of hydroxyurea and bone marrow transplant on Anti-Müllerian hormone (AMH) levels in females with sickle cell anemia.
    Elchuri SV; Williamson RS; Clark Brown R; Haight AE; Spencer JB; Buchanan I; Hassen-Schilling L; Brown MR; Mertens AC; Meacham LR
    Blood Cells Mol Dis; 2015 Jun; 55(1):56-61. PubMed ID: 25976468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimüllerian hormone levels are lower in BRCA2 mutation carriers.
    Johnson L; Sammel MD; Domchek S; Schanne A; Prewitt M; Gracia C
    Fertil Steril; 2017 May; 107(5):1256-1265.e6. PubMed ID: 28476184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.